Changes in mucociliary clearance over time in children with cystic fibrosis.
HRCT
LCI
Pseudomonas aeruginosa
children with cystic fibrosis
mucociliary clearance
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
26
12
2019
accepted:
17
05
2020
pubmed:
20
5
2020
medline:
12
1
2021
entrez:
20
5
2020
Statut:
ppublish
Résumé
(a) To quantify changes in mucociliary clearance (MCC) over time in children with cystic fibrosis (CF) and the relationship between MCC and rate of infection with Pseudomonas aeruginosa (PA); (b) to determine the impact of MCC on the evolution of CF lung disease; and (c) to explore the role of mucus composition as a determinant of MCC. Children with CF, who had previously undergone an MCC measurement (visit 1), underwent the following tests 3 to 10 years later: (a) second MCC measurement (visit 2); (b) multiple breath washout to assess ventilation inhomogeneity, expressed as lung clearance index (LCI); (c) high resolution computed tomography lung scan (HRCT); and (d) induced sputum test. Number of PA + cultures/year between visits was documented and mucus dry weight was quantified in the children and adult controls. Nineteen children completed both visits. Median time between visits was 4.6 years. Clearance declined 30% between visits. Lower MCC on visit 2 was associated with more PA+ cultures/year between visits. Lower MCC values on visit 1 were associated with higher LCI values and higher HRCT scores on visit 2. Mucus dry weight was significantly higher in children with CF compared with controls. Higher dry weights were associated with lower MCC. Mucociliary clearance declines significantly over time in children with CF. The decline is associated with PA infection rate and is affected by mucus composition. Children with early slowing of MCC appear to be at risk for developing ventilation inhomogeneity and parenchymal lung damage when they are older.
Identifiants
pubmed: 32427408
doi: 10.1002/ppul.24858
pmc: PMC7674244
mid: NIHMS1605971
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2307-2314Subventions
Organisme : NIH HHS
ID : R01 HL129925
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001079
Pays : United States
Organisme : NIH HHS
ID : UL1 TR001079
Pays : United States
Organisme : NIH HHS
ID : R01 HL080396
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL080396
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130938
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003098
Pays : United States
Organisme : NIH HHS
ID : R01 HL130938
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL129925
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Eur Respir J. 2013 Mar;41(3):507-22
pubmed: 23397305
Am J Physiol Lung Cell Mol Physiol. 2016 May 1;310(9):L860-7
pubmed: 26968767
J Clin Invest. 2014 Jul;124(7):3047-60
pubmed: 24892808
J Immunol. 2005 Jul 15;175(2):1090-9
pubmed: 16002710
Thorax. 2008 Feb;63(2):96-7
pubmed: 18234652
Am J Respir Crit Care Med. 2005 Feb 15;171(4):371-8
pubmed: 15531750
Pediatr Radiol. 2014 Dec;44(12):1496-506
pubmed: 25164326
Proc Am Thorac Soc. 2007 Aug 1;4(4):399-405
pubmed: 17652507
J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):157-64
pubmed: 23517172
Methods Mol Biol. 2012;842:49-66
pubmed: 22259129
PLoS One. 2013;8(3):e58658
pubmed: 23527003
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Nature. 2014 Jan 16;505(7483):412-6
pubmed: 24317696
Thorax. 2008 Feb;63(2):129-34
pubmed: 17675316
J Thorac Imaging. 2006 Mar;21(1):14-21
pubmed: 16538150
J Aerosol Med Pulm Drug Deliv. 2019 Aug;32(4):189-199
pubmed: 30964381
BMC Pulm Med. 2011 Sep 06;11:45
pubmed: 21896198
J Pediatr. 2014 Apr;164(4):839-45
pubmed: 24373575
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Pediatr Pulmonol. 2002 Jun;33(6):483-91
pubmed: 12001283
JCI Insight. 2018 Dec 20;3(24):
pubmed: 30568035
Am J Respir Crit Care Med. 2007 Apr 15;175(8):822-8
pubmed: 17234902
Cell. 1998 Dec 23;95(7):1005-15
pubmed: 9875854
Am J Respir Crit Care Med. 2005 Feb 1;171(3):249-56
pubmed: 15516530
J Allergy Clin Immunol. 1998 Apr;101(4 Pt 1):475-83
pubmed: 9564800
J Clin Invest. 2016 Jun 1;126(6):2367-71
pubmed: 27183390
Am J Respir Crit Care Med. 2019 Mar 15;199(6):715-727
pubmed: 30352166